Growth Metrics

Veon (VEON) EBITDA (2016 - 2025)

Historic EBITDA for Veon (VEON) over the last 17 years, with Q2 2025 value amounting to $678.0 million.

  • Veon's EBITDA rose 35810.81% to $678.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 billion, marking a year-over-year increase of 11403.16%. This contributed to the annual value of $1.6 billion for FY2024, which is 1256.87% up from last year.
  • Latest data reveals that Veon reported EBITDA of $678.0 million as of Q2 2025, which was up 35810.81% from $148.0 million recorded in Q4 2024.
  • Veon's 5-year EBITDA high stood at $1.6 billion for Q4 2021, and its period low was -$38.0 million during Q1 2021.
  • Over the past 5 years, Veon's median EBITDA value was $128.5 million (recorded in 2023), while the average stood at $294.0 million.
  • Within the past 5 years, the most significant YoY rise in Veon's EBITDA was 244857.14% (2021), while the steepest drop was 32222.22% (2021).
  • Veon's EBITDA (Quarter) stood at $1.6 billion in 2021, then crashed by 89.72% to $169.0 million in 2022, then crashed by 35.5% to $109.0 million in 2023, then soared by 35.78% to $148.0 million in 2024, then soared by 358.11% to $678.0 million in 2025.
  • Its EBITDA stands at $678.0 million for Q2 2025, versus $148.0 million for Q4 2024 and $148.0 million for Q2 2024.